Trial Profile
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 25 Sep 2023 Status changed from recruiting to completed.
- 02 May 2022 Planned End Date changed from 1 Mar 2022 to 1 Mar 2023.
- 02 May 2022 Planned primary completion date changed from 20 Jan 2022 to 20 Jan 2023.